Linked e-resources
Details
Table of Contents
Epigenetic and pluripotency aspects of disseminated cancer cells during minimal residual disease / Maria Jose Carlini, Nitisha Shrivastava, Maria Soledad Sosa
Anti-angiogenic therapy-mediated endothelial damage: a driver of breast cancer recurrence? / Laura Pisarsky, Cyrus M. Ghajar
Minimal residual disease in prostate cancer / Frank C. Cackowski, Russell S. Taichman
Minimal residual disease in head and neck cancer and esophageal cancer / Christoph Sproll, Georg Fluegen, Nikolas H. Stoecklein
Detection of minimal residual disease and its clinical applications in melanoma and breast cancer patients / Selena Y. Lin, Javier I. J. Orozco, Dave S. B. Hoon
Preservation of quiescent chronic myelogenous leukemia stem cells by the bone marrow microenvironment / Mansi Shah, Ravi Bhatia
Minimal residual disease in acute myeloid leukemia / Alexandra Gomez-Arteaga, Monica L. Guzman
Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia / Irmela Jeremias, Denis M. Schewe
Minimal residual disease in multiple myeloma: impact on response assessment, prognosis and tumor heterogeneity / Natalie Berger, Seunghee Kim-Schulze, Samir Parekh
Anti-angiogenic therapy-mediated endothelial damage: a driver of breast cancer recurrence? / Laura Pisarsky, Cyrus M. Ghajar
Minimal residual disease in prostate cancer / Frank C. Cackowski, Russell S. Taichman
Minimal residual disease in head and neck cancer and esophageal cancer / Christoph Sproll, Georg Fluegen, Nikolas H. Stoecklein
Detection of minimal residual disease and its clinical applications in melanoma and breast cancer patients / Selena Y. Lin, Javier I. J. Orozco, Dave S. B. Hoon
Preservation of quiescent chronic myelogenous leukemia stem cells by the bone marrow microenvironment / Mansi Shah, Ravi Bhatia
Minimal residual disease in acute myeloid leukemia / Alexandra Gomez-Arteaga, Monica L. Guzman
Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia / Irmela Jeremias, Denis M. Schewe
Minimal residual disease in multiple myeloma: impact on response assessment, prognosis and tumor heterogeneity / Natalie Berger, Seunghee Kim-Schulze, Samir Parekh